| Fibrocystin | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | Fibrocystin | ||||||
| InterPro | IPR029927 | ||||||
| Membranome | 632 | ||||||
| |||||||
Fibrocystin is a large, receptor-like protein that in humans is encoded by the PKHD1 gene. It is thought to be involved in the tubulogenesis and/or maintenance of duct-lumen architecture of epithelium.
The PKHD1 gene is located at chromosomal locus 6p12.2 and encodes fibrocystin. It contains numerous exons and introns and produces multiple transcripts through alternative splicing.
Fibrocystin is found in the epithelial cells lining the renal tubules and bile ducts.
The large size of fibrocystin has limited its experimental structural characterization and complicated computational prediction of its full domain architecture. Joshua Pillai, Matthew Sampson, and John Sayer from Boston Children's Hospital have introduced a computational model known as the serpentine model, which proposes a complete domain architecture for fibrocystin.
Fibrocystin, also known as polyductin (FPC), localizes to the primary cilia of renal epithelial cells, where it colocalizes with polycystin-2 (PC2), a cation channel encoded by PKD2. In mice lacking functional fibrocystin, renal polycystin-2 protein levels were reduced, and cultured renal epithelial cells from these mice showed lower polycystin-2 channel activity. These findings suggest that fibrocystin helps regulate polycystin-2 and that the two proteins may act in a common pathway involved in renal tubule formation.
Biallelic pathogenic variants in PKHD1 cause autosomal recessive polycystic kidney disease (ARPKD), which is characterized by cystic dilation of the renal tubules and bile ducts. Disease-causing variants include truncating variants and missense variants. Some deep-intronic variants can cause a pseudoexon to be included in the mature transcript, introducing a premature stop codon. A variant of this kind has been reported in Israeli Bedouin families with ARPKD.
In a cohort of 304 patients with ARPKD, missense variants affecting fibrocystin residues 709–1837 were associated with a lower risk of kidney failure, while variants affecting residues 1838–2624 were associated with more favorable liver outcomes. The serpentine model offers possible structural explanations for these associations. It places variants in the first region on the protein surface and suggests that variants in the second region may be less destabilizing.